Meeting
2011 ASCO Annual Meeting
Stereotactic body radiation therapy versus high-dose conventional radiation therapy in early-stage NSCLC: A retrospective study on local failure and survival rates.
Authors
S. Jeppesen
Department of Oncology, Odense University Hospital, Odense, Denmark
S. Jeppesen , T. Schytte , H. R. Jensen , C. Brink , O. Hansen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer - Local-regional and Adjuvant Therapy/Small Cell
Track
Lung Cancer
Sub Track
Local-Regional Therapy
Citation
J Clin Oncol 29: 2011 (suppl; abstr 7049)
Abstract #
7049
Poster Bd #
22E
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Stereotactic ablative radiotherapy with nivolumab for early-stage operable non-small cell lung cancer: A phase 2 study.
First Author: Gustavo Schvartsman
Poster
2021 ASCO Annual Meeting
Prognostic value of SUVmax on FDG-PET/CT before and after stereotactic body radiotherapy (SBRT) on recurrence and survival in early-stage non-small cell lung cancer (NSCLC).
First Author: Saarang Deshpande
Poster
2014 ASCO Quality Care Symposium
Outcomes in stage I non-small cell lung cancer following the introduction of stereotactic body radiotherapy in Alberta, Canada.
First Author: Marc Kerba
Poster
2013 ASCO Annual Meeting
RTOG 0618: Stereotactic body radiation therapy (SBRT) to treat operable early-stage lung cancer patients.
First Author: Robert D. Timmerman